Cutaneous side effects in a cohort of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: General description and further characterization, correlation with photoexposition and study of hypopigmentation as treatment's prognostic factor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cutaneous side effects in a cohort of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: General description and further characterization, correlation with photoexposition and study of hypopigmentation as treatment's prognostic factor

Published:2020-11 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Llamas‐Velasco Mar¹²^ORCID,Ovejero‐Merino Enrique²,García‐Diez Amaro¹,Requena Luis³,Daudén Esteban¹,Steegmann Juan Luis⁴

Affiliation:

1. Department of Dermatology Fundación de Investigación Biomédica de La Princesa, Hospital Universitario de La Princesa Madrid Spain

2. Voth Laboratorio Diagnóstico Madrid Spain

3. Department of Dermatology Fundación Jiménez Diaz Madrid Spain

4. Department of Hematology Hospital Universitario de La Princesa Madrid Spain

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14428

Reference34 articles.

1. A Case of Cutaneous Rosai-Dorfman Disease Refractory to Imatinib Therapy

2. Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib

3. Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia

4. Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience

5. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia;Pediatric Dermatology;2023-12-27

2. Verruca Vulgaris Eruption Arising in the Setting of a Tyrosine Kinase Inhibitor;Cureus;2022-06-16

3. Ocular Toxicity of Targeted Anticancer Agents;Drugs;2021-03-31

4. Imatinib/nilotinib;Reactions Weekly;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3